Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Lifitegrast

SKU: orb1303486

Description

Lifitegrast (SAR 1118) is a small molecule antagonist of lymphocyte function-associated antigen-1 (LFA-1). It is used in research to investigate cell adhesion and immune signaling pathways, with applications in studying inflammatory conditions such as dry eye disease in both in vitro and in vivo models.

Research Area

Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

Key Properties

CAS Number1025967-78-5
MW615.48
Purity99.66% (May vary between batches)
FormulaC29H24Cl2N2O7S
SMILESCS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3CN(CCc3c2Cl)C(=O)c2ccc3ccoc3c2)C(O)=O)c1
TargetIntegrin
SolubilityDMSO:245 mg/mL (398.06 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.25 mM)

Bioactivity

Target IC50
LFA1:2.98 nM.
In Vivo
Lifitegrast, has potent anti-inflammatory activity on corneal inflammation induced by antibiotic-killed P. aeruginosa and S. aureus in the presence of a silicone hydrogel lens with the optimal application being a 1% solution applied either 2 or 3 times prior. Topical application of lifitegrast to the corneal surface of healthy adults is safe and well tolerated. SAR 1118 ophthalmic drops administered thrice daily deliver therapeutic levels of SAR 1118 in the retina and can alleviate the retinal complications associated with diabetes.
In Vitro
Lifitegrast is a novel small molecule integrin antagonist that inhibits T cell-mediated inflammation by blocking the binding of two important cell surface proteins (lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1), thus lessening overall inflammatory responses. Lifitegrast strongly inhibits Jurkat T cell attachment to ICAM-1 with an IC50 of 2.98 nM.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

ICAM-1, Integrin, Inhibitor, LFA-1, inflammatory cycle, Lifitegrast, Jurkat T, inhibit, dry eye disease, T cell, SAR1118, SAR-1118, SAR 1118, SHP 606, SHP606, SHP-606

Similar Products

  • Lifitegrast sodium [orb1691063]

    99.33% (May vary between batches)

    1119276-80-0

    637.46

    C29H23Cl2N2NaO7S

    5 mg, 1 mg
  • Lifitegrast impurity 6 [orb3181197]

    1270093-99-6

    243.28

    C10H13NO4S

    50 mg, 10 mg
  • Lifitegrast [orb1227126]

    >98% (HPLC)

    1025967-78-5

    615.4811

    C29H24Cl2N2O7S

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 g, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

5 mg
$ 80.00
1 ml x 10 mM (in DMSO)
$ 90.00
10 mg
$ 100.00
25 mg
$ 140.00
50 mg
$ 190.00
100 mg
$ 280.00
500 mg
$ 630.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry